Maximal thymectomy in children with myasthenia gravis

Eur J Cardiothorac Surg. 2003 Aug;24(2):187-9; discussion 190-1. doi: 10.1016/s1010-7940(03)00299-9.

Abstract

Objectives: We performed this study to evaluate the benefit of thymectomy in children with myasthenia gravis (MG).

Methods: Over a period of 15 years from 1986 to 2001, we collected data on 30 children with MG and retrospectively reviewed the outcome of maximal thymectomy.

Results: There were 23 females and seven males with a mean age of 13.2 years (range 4-16). The mean duration of the disease was 19.3 months (range 2-144). According to Osserman classification, there were 14 children in class II; 12 in class III; and four children in class IV. One child in class IV required postoperative ventilation and one was re-explored to drain a pericardial effusion secondary to central line leak. We found ectopic thymic tissue in 10 cases (33.3%). During a mean follow-up period of 53.5 months (range 9-180), complete remission was noted in 13 children (43.4%) and improvement in 14 (46.6%). The remaining three children (10%) did not improve following surgery. Univariate analysis (P < 0.05) showed that ectopic thymic tissue is a significant prognostic factor for outcome.

Conclusion: Maximal thymectomy appears to provide a high rate of remission and improvement in children with MG. However, the presence of ectopic thymic tissue has poor prognostic value.

MeSH terms

  • Adolescent
  • Chi-Square Distribution
  • Child
  • Child, Preschool
  • Choristoma / surgery*
  • Female
  • Follow-Up Studies
  • Humans
  • Male
  • Myasthenia Gravis / surgery*
  • Prognosis
  • Retrospective Studies
  • Thymectomy*
  • Treatment Outcome